Researchers at the University of Colorado Anschutz Medical Campus have helped confirm the dosing, safety and effectiveness of a drug formulation designed for treating children with human ...
LONDON, ONTARIO -- (Marketwire) -- 05/18/11 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced today that it has initiated a project to develop an optimal oral formulation of ...
Clears the way to finalize Phase 3 protocol and recruit sites for U.S. Phase 3 substantially funded by $17.0 million CPRIT grant and $8.5 million Company match Biodexa Pharmaceuticals PLC (“Biodexa” ...
Suzanne Jansen, MSc, PharmD, ICON, says early-phase clinical success depends on flexible, simple formulations that support ...
Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer. Cytostatic ...
All academic programs at RIT are required to have a Program Level Outcomes Assessment Plan (PLOAP). The goal of an academic program assessment plan is to facilitate continuous program improvement. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results